200 related articles for article (PubMed ID: 32368972)
1. Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan.
Al-Eitan LN; Al-Maqableh HW; Mohammad NN; Hakooz NM; Dajani RB
Curr Drug Metab; 2020; 21(4):307-317. PubMed ID: 32368972
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphisms of Pharmacogenomic VIP Variants in the Circassian Subpopulation from Jordan.
Al-Eitan LN; Mohammad NN; Al-Maqableh HW; Hakooz NM; Dajani RB
Curr Drug Metab; 2019; 20(8):674-681. PubMed ID: 31362667
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of pharmacogenomic VIP variants in the Yi population from China.
Yan M; Li D; Zhao G; Li J; Niu F; Li B; Chen P; Jin T
Gene; 2018 Mar; 648():54-62. PubMed ID: 29337087
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
Al-Eitan LN
Gene; 2020 May; 737():144408. PubMed ID: 32007583
[TBL] [Abstract][Full Text] [Related]
5. Inter and intra-ethnic differences in the distribution of the molecular variants of TPMT, UGT1A1 and MDR1 genes in the South Indian population.
Umamaheswaran G; Krishna Kumar D; Kayathiri D; Rajan S; Shewade DG; Dkhar SA; Manjunath S; Ushakiran P; Reneega G; Ritushree K; Adithan C
Mol Biol Rep; 2012 May; 39(5):6343-51. PubMed ID: 22318545
[TBL] [Abstract][Full Text] [Related]
6. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms.
Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M
Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428
[TBL] [Abstract][Full Text] [Related]
7. Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population.
Abudahab S; Hakooz N; Jarrar Y; Al Shahhab M; Saleh A; Zihlif M; Dajani R
Curr Drug Metab; 2019; 20(5):399-410. PubMed ID: 31132973
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan.
Al-Eitan LN; Rababa'h DM; Hakooz NM; Alghamdi MA; Dajani RB
Pharmgenomics Pers Med; 2020; 13():199-215. PubMed ID: 32765042
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 single nucleotide polymorphisms in the Brazilian population.
Scheiner MA; Damasceno AM; Maia RC
Mol Biol Rep; 2010 Jan; 37(1):111-8. PubMed ID: 19437139
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.
Jmel H; Romdhane L; Ben Halima Y; Hechmi M; Naouali C; Dallali H; Hamdi Y; Shan J; Abid A; Jamoussi H; Trabelsi S; Chouchane L; Luiselli D; Abdelhak S; Kefi R
PLoS One; 2018; 13(4):e0194842. PubMed ID: 29652911
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
[TBL] [Abstract][Full Text] [Related]
12. Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.
Jin T; Aikemu A; Zhang M; Geng T; Feng T; Kang L; Luo ML
Med Sci Monit; 2015 Dec; 21():3769-76. PubMed ID: 26632549
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of pharmacogenomic VIP variants in the Mongol of Northwestern China.
Jin T; Shi X; Wang L; Wang H; Feng T; Kang L
BMC Genet; 2016 May; 17(1):70. PubMed ID: 27233804
[TBL] [Abstract][Full Text] [Related]
14. The population genetics of pharmacogenomics VIP variants in the Sherpa population.
Wang L; Ren Y; Shi X; Yuan D; Liu K; Geng T; Li G; Kang L; Jin TB
Drug Metab Pharmacokinet; 2016 Feb; 31(1):82-89. PubMed ID: 26825850
[TBL] [Abstract][Full Text] [Related]
15. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
Sortica Vde A; Ojopi EB; Genro JP; Callegari-Jacques S; Ribeiro-Dos-Santos A; de Moraes MO; Romano-Silva MA; Pena SD; Suarez-Kurtz G; Hutz MH
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):460-8. PubMed ID: 22136368
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphisms of ABCB1 gene and response to etanercept treatment in patients with ankylosing spondylitis in a Chinese Han population.
Yan RJ; Lou TT; Wu YF; Chen WS
Medicine (Baltimore); 2017 Feb; 96(5):e5929. PubMed ID: 28151874
[TBL] [Abstract][Full Text] [Related]
19. Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan.
Al-Eitan LN; Rababa'h DM; Hakooz NM; Alghamdi MA; Dajani RB
J Pers Med; 2020 Jan; 10(1):. PubMed ID: 31935801
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
Li D; Peng L; Xing S; He C; Jin T
BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
